Mode
Text Size
Log in / Sign up

Diabetes-specific nutritional formulas reduce mean blood glucose by 0.54 mmol/L in patients with hyperglycemiaSpecialized Nutrition Formulas May Improve Blood Sugar in Tube Feeding

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Consider using diabetes-specific nutritional formulas to improve glycemic control in critically ill and long-term care patients.

This meta-analysis evaluates the efficacy of diabetes-specific nutritional formulas (DSNF) compared to standard formulas for managing hyperglycemia in patients within critical care and long-term care settings. The analysis included 483 patients in critical care and 137 in long-term care. The authors conclude that DSNF provides statistically significant improvements in glycemia for both populations.

Key findings include a reduction in mean blood glucose in critically ill patients by 0.54 mmol/L (95% CI -0.78 to -0.31, p<0.001). Additionally, the coefficient of variation of glucose decreased by 6.56% (95% CI -12.55% to -0.57%, p=0.032) and the SD of glucose decreased by 0.77 mmol/L (95% CI -1.49 to -0.06, p=0.035) in the critically ill population. In long-term care settings, hemoglobin A1c was reduced by 0.92% (95% CI -1.72% to -0.13%, p=0.023).

Several limitations were noted, including small effect sizes, imprecision, and substantial statistical heterogeneity. While the mean blood glucose reduction is reported with moderate certainty, the findings for coefficient of variation, SD of glucose, and hemoglobin A1c are reported with low certainty. These results suggest that DSNF may be a viable intervention for glycemic control in tube feeding, though the magnitude of effect for some secondary markers remains uncertain.

How this fits prior evidence

This meta-analysis addresses a gap in management strategies for the high incidence of hyperglycemia in critically ill patients, which was previously noted to occur in 30% to 80% of cases during enteral nutrition. While the previous evidence established the high prevalence of hyperglycemia in these settings, this study provides evidence that DSNF specifically can reduce mean blood glucose by 0.54 mmol/L and improve other glycemic markers compared to standard formulas.

Researchers analyzed data from several trials to see if diabetes-specific nutritional formulas (DSNF) work better than standard formulas for patients with high blood sugar. The study looked at two groups: patients in critical care and those in long-term care who received nutrition through tubes.

In the critical care group, the study found that the specialized formulas led to a decrease in mean blood glucose levels. They also found a reduction in the variation of blood glucose levels, which can help keep blood sugar more stable. For patients in long-term care, the specialized formulas were linked to a lower hemoglobin A1c level.

While the results show a positive link, the evidence is not perfectly clear. Some findings were based on small sample sizes or had less certainty. Because the study is a meta-analysis of different trials, the results are useful for understanding general trends but may not apply to every individual patient. Patients and doctors should discuss these findings to see if a change in formula is appropriate for a specific care plan.

What this means for you:
Specialized nutrition formulas may help manage blood sugar in patients receiving tube feeding.

Common questions

Who can benefit from these specific nutrition formulas?

These formulas are intended for patients with hyperglycemia who are receiving nutrition through a tube. The study specifically looked at two groups: those in critical care settings and those in long-term care settings. The results suggest these formulas may help manage blood sugar in both of these groups.

How did the formulas affect blood sugar in critical care?

In the critical care group, the study found that the specialized formulas led to a decrease in mean blood glucose by 0.54 mmol/L. They also showed a reduction in the coefficient of variation of glucose by 6.56% and a reduction in the standard deviation of glucose by 0.77 mmol/L.

Were there any reported safety concerns with these formulas?

The study did not report any specific adverse events, serious adverse events, or issues with how well the patients tolerated the formulas. However, because the study had some limitations like small effect sizes and imprecision, you should talk to a doctor about specific safety for any patient.

Study Details

Study typeMeta analysis
Sample sizen = 483
EvidenceLevel 1
PublishedSep 2026
View Original Abstract ↓
This systematic review was conducted to evaluate the effects of diabetes-specific nutritional formulas (DSNF) in tube feeding on multiple outcomes in patients with hyperglycemia in real-world clinical settings. Randomized controlled trials (RCTs) comparing outcomes of patients receiving tube feeding with DSNF versus standard formulas were evaluated. RCTs in critical care and long-term care settings were addressed separately. Outcomes reported by two or more RCTs per clinical setting were evaluated, and those addressed by three or more RCTs were assessed using meta-analysis. Five RCTs allocating 483 patients in critical care and three RCTs allocating 137 patients in long-term care met inclusion criteria. DSNF showed advantages over standard formulas for glycemic control in both populations. Meta-analysis of studies enrolling critically ill patients found reductions in mean blood glucose (mean difference (MD) -0.54 mmol/L (95% CI -0.78 to -0.31), p<0.001; I=9%; moderate certainty), coefficient of variation of glucose (MD -6.56% (95% CI -12.55% to -0.57%), p=0.032; I=98%; low certainty) and SD of glucose (-0.77 mmol/L (95% CI -1.49 to -0.06), p0.035; I=98%; low certainty). Meta-analysis of the studies enrolling patients in long-term care found a reduction in hemoglobin A1c (-0.92% (95% CI -1.72% to -0.13%), p0.023; I=85%; low certainty). Findings for other outcomes were uncertain due to a lack of reporting in the included publications, inconsistent findings across studies, small sample sizes or lack of overall statistical significance. Evidence from this review demonstrated that DSNF in tube feeding provides statistically significant improvements in glycemia in both critically ill and long-term care populations with hyperglycemia compared with standard formulas. However, small effect sizes, imprecision and substantial statistical heterogeneity reduced certainty in the strength of evidence for most outcomes. DSNF is an important clinical tool to control hyperglycemia among critically ill and long-term care patients and should continue to be assessed for effectiveness in improving outcomes.CRD420251105442.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.